Top compounds associated with response to LILRB3

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	tanespimycin:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.0041	0.9
mRNA	AM-580	CTRPv2	pan-cancer	AAC	0.0041	0.9
mRNA	BRD8899	CTRPv2	pan-cancer	AAC	-0.0042	0.9
mRNA	TG-100-115	CTRPv2	pan-cancer	AAC	0.0038	0.9
mRNA	KH-CB19	CTRPv2	pan-cancer	AAC	0.0047	0.9
mRNA	CHM-1	CTRPv2	pan-cancer	AAC	0.0032	0.9
mRNA	linifanib	CTRPv2	pan-cancer	AAC	-0.0034	0.9
mRNA	AZD0530	CTRPv2	pan-cancer	AAC	0.0035	0.9
mRNA	ISOX	CTRPv2	pan-cancer	AAC	0.003	0.9
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.0032	0.9

Download CSV